tiprankstipranks
Cingulate Inc. Stockholders Bolster Governance and Growth Strategy
PremiumCompany AnnouncementsCingulate Inc. Stockholders Bolster Governance and Growth Strategy
1M ago
Cingulate receives confirmation from FDA on NDA for CTx-1301
PremiumThe Fly
Cingulate receives confirmation from FDA on NDA for CTx-1301
2M ago
Cingulate files to sell 2M shares of common stock for holders
PremiumThe Fly
Cingulate files to sell 2M shares of common stock for holders
2M ago
Cingulate Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Clinical and Business Update
PremiumPress ReleasesCingulate Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Clinical and Business Update
4M ago
Cingulate reports Q4 EPS net loss $6.9M
PremiumThe Fly
Cingulate reports Q4 EPS net loss $6.9M
4M ago
Cingulate to Participate in Benzinga All Live Access Event
PremiumPress Releases
Cingulate to Participate in Benzinga All Live Access Event
4M ago
Cingulate Announces Closing of $7.5 Million Public Offering
PremiumPress ReleasesCingulate Announces Closing of $7.5 Million Public Offering
5M ago
Cingulate Announces Pricing of $7.5 Million Public Offering
PremiumPress Releases
Cingulate Announces Pricing of $7.5 Million Public Offering
6M ago
Cingulate prices 3.75M shares at $2.00 in public offering
PremiumThe Fly
Cingulate prices 3.75M shares at $2.00 in public offering
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100